Author Archives: papapolitis

Sale of INTRACOM DEFENSE to IAI – Israel Aerospace Industries

Papapolitis & Papapolitis advised ATHEX listed conglomerate Intracom Holdings (ATHEX: INTKA) and Intracom Technologies in the sale of the 90.91% shareholding participation in INTRACOM DEFENSE to IAI – Israel Aerospace Industries.

Lamda Development €300Million Joint Venture with Temes S.A.

Papapolitis & Papapolitis advised Lamda Development on the completion of two strategic cooperation agreements with TEMES SA for the €300 Million joint development of two state-of-the-art, luxury 5-star hotels and the corresponding branded residences on the coastal front of Elliniko, in southern Athens , with a construction completion horizon of these developments at the end

ECM Acquisition of Pavlides Marbles

Papapolitis & Papapolitis advised Pavlidis Marbles SA / ECM Partners in relation to the 100% acquisition of the Pavlidis Marbles Group.

Intracom Holdings investment in KLM S.A.

P&P advised Intracom Holdings on its acquisition of a percentage of 27.6% in the listed company KLM SA and on the signing of a MoU with the majority shareholders for the acquisition of an additional percentage of 46.60% in KLM SA

Our Managing Partner Nicholas Papapolitis has been listed in the Leaders category of the 100 most influential Greek personalities of 2022, in the Mononews 100 list.

Our Managing Partner Nicholas Papapolitis has been listed in the Leaders category of the 100 most influential Greek personalities of 2022, in the Mononews 100 list. Mononews 100 includes those personalities that with their work and presence left their mark in the Greek market and society in 2022. To read the full list please visit

Invel Real Estate and Prodea Investments acquisition of White Coast Hotel

Papapolitis & Papapolitis advised Invel Real Estate and Prodea Investments REIC in relation to the acquisition of the White Coast hotel located on Milos Island

Lavipharm share capital increase

Papapolitis & Papapolitis advised Ambrosia Capital as Lead Underwriter in relation to the €58m pre-emptive share capital increase of Lavipharm S.A., a leading pharmaceutical company with global presence, and to the public offer in Greece of newly issued shares listed on Athex. P&P advised the Lead Underwriter on all aspects of the transaction including customary

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.